O5 The expression profile of host restriction factors in different cohorts of HIV-1-infected patients

• C. Van Hecke,
• E. Malatinkova,
• W. De Spiegelaere,
• M. Sips,
• K. Vervisch,
• C. Verhofstede,
• M. Johnson,
• S. Kinloch-de Loës,
• W. Trypsteen,
• L. Vandekerckhove

Affiliations

C. Van Hecke

HIV Cure Research Center, UGent, Belgium; Department of Morphology, UGent, Belgium; AIDS Reference Laboratory, UGent, Belgium; Royal Free Hospital, London, UK

E. Malatinkova

HIV Cure Research Center, UGent, Belgium; Department of Morphology, UGent, Belgium; AIDS Reference Laboratory, UGent, Belgium; Royal Free Hospital, London, UK

W. De Spiegelaere

HIV Cure Research Center, UGent, Belgium; Department of Morphology, UGent, Belgium; AIDS Reference Laboratory, UGent, Belgium; Royal Free Hospital, London, UK

M. Sips

HIV Cure Research Center, UGent, Belgium; Department of Morphology, UGent, Belgium; AIDS Reference Laboratory, UGent, Belgium; Royal Free Hospital, London, UK

K. Vervisch

HIV Cure Research Center, UGent, Belgium; Department of Morphology, UGent, Belgium; AIDS Reference Laboratory, UGent, Belgium; Royal Free Hospital, London, UK

C. Verhofstede

HIV Cure Research Center, UGent, Belgium; Department of Morphology, UGent, Belgium; AIDS Reference Laboratory, UGent, Belgium; Royal Free Hospital, London, UK

M. Johnson

HIV Cure Research Center, UGent, Belgium; Department of Morphology, UGent, Belgium; AIDS Reference Laboratory, UGent, Belgium; Royal Free Hospital, London, UK

S. Kinloch-de Loës

HIV Cure Research Center, UGent, Belgium; Department of Morphology, UGent, Belgium; AIDS Reference Laboratory, UGent, Belgium; Royal Free Hospital, London, UK

W. Trypsteen

HIV Cure Research Center, UGent, Belgium; Department of Morphology, UGent, Belgium; AIDS Reference Laboratory, UGent, Belgium; Royal Free Hospital, London, UK

L. Vandekerckhove

HIV Cure Research Center, UGent, Belgium; Department of Morphology, UGent, Belgium; AIDS Reference Laboratory, UGent, Belgium; Royal Free Hospital, London, UK